Key facts
as of Oct 2026- Developer of a workflow automation platform designed for medical practices.
- Medsender is valued at approximately $25.0M as of Oct 2026, set at its later-stage round, Jan 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $7.5M across 1 recorded rounds; the latest was Early Stage VC ($7.5M) in Jan 2025.
- Notable investors include 450 Ventures, Ballast Point Ventures, Mentors Fund.
- Medsender has filed 1 Form D with the SEC, most recently Jan 2025 ($7.5M sold to 31 investors).
- Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence$25.0M
Valued at $25.0M at its later-stage round, Jan 2025. Nothing has traded since.
Free account
More of Medsender with a free account
- ·Watch Medsender: the Monday email on marks, rounds and moves
Create free account
No card required
Funding rounds
1 roundsAbout Medsender
Developer of a workflow automation platform designed for medical practices. The company's platform uses artificial intelligence to extract, structure, and sync data from unstructured sources such as faxes into patient charts that eliminate manual tasks, enabling doctors and staff of health organizations to send and receive health records digitally.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2015
- Employees
- 27
- Website
- medsender.com/
- Ownership
- Privately Held (backing)